CryoCor soars on favourable US panel vote and Boston Scientific deal
This article was originally published in Clinica
Executive Summary
CryoCor has received a double boost after US FDA advisors recommended approval for its cryoablation treatment for atrial flutter and Boston Scientific announced it had formed a strategic collaboration with the firm.